Jamie B. Andreyka

Lysosomal Trafficking and Cysteine Protease Metabolism Confer Target-specific Cytotoxicity by Peptide-linked Anti-CD30-Auristatin Conjugates

May S.K. Sutherland, Russell J. Sanderson, Kristine A. Gordon et al. · Journal of Biological Chemistry · 2006 · 291 citations · Full text

Engineered antibody-drug conjugates with defined sites and stoichiometries of drug attachment

Charlotte F. McDonagh, Eileen Turcott, Lori Westendorf et al. · Protein Engineering Design and Selection · 2006 · 236 citations · Full text

Medicinal Chemistry, Parental Antibody-drug Conjugates, Medicine +15

Development and Properties of β-Glucuronide Linkers for Monoclonal Antibody−Drug Conjugates

Scott C. Jeffrey, Jamie B. Andreyka, Starr X. Bernhardt et al. · Bioconjugate Chemistry · 2006 · 166 citations

Immunology, Glycobiology, Mmaf Conjugate C1f6-9b +16

Design, Synthesis, and in Vitro Evaluation of Dipeptide-Based Antibody Minor Groove Binder Conjugates

Scott C. Jeffrey, Michael Torgov, Jamie B. Andreyka et al. · Journal of Medicinal Chemistry · 2005 · 89 citations

SGN-35, an Anti-CD30 Antibody-Drug Conjugate, Exhibits Potent Antitumor Activity for the Treatment of CD30+ Malignancies.

Kevin J. Hamblett, Jeremy Barton, Charles G. Cerveny et al. · Blood · 2005 · 16 citations